Latest Regulatory News

Nufarm Finance (NZ) Limited reported a modest 1.1% rise in net profit to $20.53 million for the year ended September 2025, alongside increased distributions to security holders and maintained strong liquidity backed by its parent company.

Northern Minerals has applied to defer its 2025 AGM as it awaits regulatory review over potential foreign investment breaches, underscoring heightened scrutiny on shareholder compliance.

Aurumin Limited’s acquisition by Brightstar Resources has been legally approved, triggering a share exchange and imminent delisting from the ASX.

Genesis Minerals has secured crucial rail agreements that clear the path for developing the Tower Hill open pit gold mine and expanding the Leonora mill, targeting first ore in FY28.

Embark Early Education has revised the timeline for its conditional takeover bid of Mayfield Childcare, delaying key regulatory filings into early 2026.

Lodestar Minerals has responded to ASX queries clarifying the timing and disclosure of key assay results from its Ned’s Creek gold project and detailed the procedural steps behind its Arizona Mountain Pass rare earths acquisition.

The Star Entertainment Group has secured crucial regulatory approvals to convert a $300 million strategic investment by Bally’s Corporation and Investment Holdings into equity, setting the stage for board changes and a path toward financial recovery.

Webjet Group has received a revised non-binding takeover offer from BGH Capital at A$0.91 per share, up from a previous A$0.80 bid, signaling renewed acquisition interest amid ongoing negotiations.

VHM Limited launches a fully underwritten A$10.3 million placement and a $1 million share purchase plan to fund the Goschen rare earths project, supported by strategic government financing.

Bindi Metals Limited has announced a non-renounceable entitlement offer of options to raise approximately $46,000, underwritten by CPS Capital Group. The offer includes 46 million options to shareholders and 5 million options to the lead manager, with potential dilution if exercised.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Great Northern Minerals has secured a listing on the OTCQB Venture Market, enhancing its access to North American investors as it advances critical minerals projects in the US.